PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New RNA-based therapeutic strategies for controlling gene expression

New RNA-based therapeutic strategies for controlling gene expression
2012-02-06
(Press-News.org) New Rochelle, NY, February 2, 2012—Small RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which RNA drugs can control gene activity. A comprehensive review article in Nucleic Acid Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc., details these advances.

Short strands of nucleic acids, called small RNAs, can be used for targeted gene silencing, making them attractive drug candidates. These small RNAs block gene expression through multiple RNA interference (RNAi) pathways, including two newly discovered pathways in which small RNAs bind to Argonaute proteins or other forms of RNA present in the cell nucleus, such as long non-coding RNAs and pre-mRNA.

Keith T. Gagnon, PhD, and David R. Corey, PhD, University of Texas Southwestern Medical Center, in Dallas, review common features shared by RNAi pathways for controlling gene expression and focus in detail on the potential for Argonaute-RNA complexes in gene regulation and other exciting new options for targeting emerging forms of non-coding RNAs and pre-mRNAs in the article "Argonaute and the Nuclear RNAs: New Pathways for RNA Mediated Control of Gene Expression."

"The field of RNA mediated control of gene expression is rapidly evolving and the article by Gagnon and Corey provides a highly informative and up to date review of this exciting and often surprising area of biomedical research. We are delighted to publish this important review for the field," says Co-Editor-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC.



INFORMATION:

Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, and C.A. Stein, MD, PhD, Department of Oncology, Albert Einstein-Montefiore Cancer Center, Montefiore Medical Center; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).

Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the official journal of the Oligonucleotide Therapeutics Society. A complete table of contents and free sample issue may be viewed online at www.liebertpub.com/nat.

Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy and Human Gene Therapy Methods, Genetic Testing and Molecular Biomarkers, Assay and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available at www.liebertpub.com

Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
www.liebertpub.com


[Attachments] See images for this press release:
New RNA-based therapeutic strategies for controlling gene expression

ELSE PRESS RELEASES FROM THIS DATE:

Hubble zooms in on a magnified galaxy

Hubble zooms in on a magnified galaxy
2012-02-06
Thanks to the presence of a natural "zoom lens" in space, NASA's Hubble Space Telescope got a uniquely close-up look at the brightest "magnified" galaxy yet discovered. This observation provides a unique opportunity to study the physical properties of a galaxy vigorously forming stars when the universe was only one-third its present age. A so-called gravitational lens is produced when space is warped by a massive foreground object, whether it is the sun, a black hole or an entire cluster of galaxies. The light from more-distant background objects is distorted, brightened ...

'First light' taken by NASA's newest CERES instrument

First light taken by NASAs newest CERES instrument
2012-02-06
The doors are open on NASA's Suomi NPP satellite and the newest version of the Clouds and the Earth's Radiant Energy System (CERES) instrument is scanning Earth for the first time, helping to assure continued availability of measurements of the energy leaving the Earth-atmosphere system. The CERES results help scientists to determine the Earth's energy balance, providing a long-term record of this crucial environmental parameter that will be consistent with those of its predecessors. CERES arrived in space Oct. 28, 2011, carried by NASA's newest Earth-observing satellite, ...

NASA satellites see wind shear battering Tropical Depression Iggy

NASA satellites see wind shear battering Tropical Depression Iggy
2012-02-06
NASA satellites have watched as wind shear has torn Cyclone Iggy apart over the last day. NASA infrared satellite imagery showed that Iggy's strongest thunderstorms have been pushed away from the storm's center and visible imagery shows the storm is being stretched out. Iggy is weakening and heading for a landfall between Geraldton and Perth. When NASA's Aqua satellite passed over Tropical Cyclone Iggy on Feb. 1 at 1805 UTC (1:05 p.m. EST), the Atmospheric Infrared Sounder (AIRS) instrument aboard captured an infrared look at the cyclone. AIRS data showed that the strongest ...

A battle of the vampires, 20 million years ago?

2012-02-06
CORVALLIS, Ore. – They are tiny, ugly, disease-carrying little blood-suckers that most people have never seen or heard of, but a new discovery in a one-of-a-kind fossil shows that "bat flies" have been doing their noxious business with bats for at least 20 million years. For bats, that's a long time to deal with a parasite doing its best vampire impression. Maybe it is nature's revenge on the vampire bat, an aggressive blood consumer in its own right that will feed on anything from sheep to dogs and humans. The find was made by researchers from Oregon State University ...

Breastfeeding and lung function at school age: Does maternal asthma modify the effect?

2012-02-06
Breastfeeding is associated with improved lung function at school age, particularly in children of asthmatic mothers, according to a new study from researchers in Switzerland and the UK. "In our cohort of school age children, breastfeeding was associated with modest improvement in forced mid-expiratory flow (FEF50) in our whole group and with improvements in forced vital capacity (FVC) and forced expiratory volume at 1 second (FEV1) only in the children of asthmatic mothers," said Claudia E. Kuehni, MD, MSc, professor at the Institute of Social and Preventive Medicine ...

Classic portrait of a barred spiral galaxy

Classic portrait of a barred spiral galaxy
2012-02-06
Most spiral galaxies in the Universe have a bar structure in their centre, and Hubble's image of NGC 1073 offers a particularly clear view of one of these. Galaxies' star-filled bars are thought to emerge as gravitational density waves funnel gas toward the galactic centre, supplying the material to create new stars. The transport of gas can also feed the supermassive black holes that lurk in the centres of almost every galaxy. Some astronomers have suggested that the formation of a central bar-like structure might signal a spiral galaxy's passage from intense star-formation ...

New procedure repairs severed nerves in minutes, restoring limb use in days or weeks

2012-02-06
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research. "We have developed a procedure which can repair severed nerves within minutes so that the behavior they control can be partially restored within days and often largely restored within two to four weeks," said Professor George Bittner from ...

New technique dissolves blood clots in the brain and lowers risk of brain damage after stroke

2012-02-06
Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage (ICH) who could function independently by 10 to 15 percent six months following the procedure. At the International Stroke Conference taking place January 31 through February 2 in New Orleans, the researchers will present their findings from 93 patients, ...

New technology to tackle treatment-resistant cancers

2012-02-06
Free-flowing cancer cells have been mapped with unprecedented accuracy in the bloodstream of patients with prostate, breast and pancreatic cancer, using a brand new approach, in an attempt to assess and control the disease as it spreads in real time through the body, and solve the problem of predicting response and resistance to therapies. In comparison to a previous generation of systems, the researchers state their test showed a significantly greater number of high-definition circulating tumour cells (HD-CTCs), in a higher proportion of patients, by using a computing-intensive ...

NYU Courant researchers weigh methods to more accurately measure genome sequencing

2012-02-06
Lost in the euphoria of the 2003 announcement that the human genome had been sequenced was a fundamental question: how can we be sure that an individual's genome has been read correctly? While the first full, individual genome was sequenced a decade ago, given the vast genetic variation across the world's seven billion people, not to mention the differences in makeup even among close relatives, the question of accurate sequencing for individuals has continued to vex researchers. With companies now projecting they can sequence a genome for a $1,000, down from $25,000 ...

LAST 30 PRESS RELEASES:

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

New research in blood cancer diagnostics to be featured at AMP 2025

Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy

Research progress on leptin in metabolic dysfunction-associated fatty liver disease

Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)

Vaccine Innovation Center, Korea University College of Medicine hosts an invited training program for Ethiopian Health Ministry officials

FAU study finds small group counseling helps children thrive at school

Research team uncovers overlooked layer of DNA that may shape disease risk

Study by Incheon National University could transform skin cancer detection with near-perfect accuracy

New study reveals how brain fluid flow predicts survival in glioblastoma

[Press-News.org] New RNA-based therapeutic strategies for controlling gene expression